Promotion of Medicinal Products for Children
The medical insight that children need special medicinal products is gaining increasing acceptance. Very often, the dosage alone is not the only way in which they should differ from products for adults. As a reaction to this fact, EC Regulation No. 1901/2006 on medicinal products for paediatric use and the amendment to the Act on Supplementary Protection Certificates now allow for the protection of medicinal products for children to be extended by a further 6 months. This aims to provide an incentive for the development of high-quality and ethically acceptable medicinal products for the treatment of children.
